Nanotechnology In Fighting Multidrug-Resistant Infections

by

Introduction

Multidrug-resistant (MDR) infections are a major global public health threat due to the effect they have on the management of otherwise easily treatable bacterial infections with longer hospital duration, increased healthcare expenditures, and higher mortality rates. These infections, including those by Staphylococcus aureus, Escherichia coli, and other drug-resistant bacteria, feed on the declining effectiveness of traditional antibiotics. As described below, nanotechnology is a possible way to solve this problem and use new methods of diagnosing, treating, and preventing MDR infections. Recent research regarding nanoscale material and delivery systems in nanoparticles has been studied to deal with MDR pathogens, inhibit biofilm formation, improve drug delivery systems, and decrease resistance. This article discusses how nanotechnology progresses to combat MDR infection and how science and technology will help save humanity.

Nanoparticles Used as Antibacterial Material

Nanoparticles (NPs) have recently been postulated as a novel generation of antibacterial materials with tremendous potential. This property enables them to compromise bacterial membrane integrity, produce ROS, and inhibit biosynthesis pathways, making them better than normal antibiotics. For instance, silver, gold, and zinc oxide nanoparticles are used due to their broad-spectrum antimicrobial activity. These nanoparticles can be developed to perturb solely the bacterial membrane, leading to cell leakage and structural disarrangement.

The natural extracts encapsulated in chitosan/alginate nanoparticles have been shown to be significantly effective against Staphylococcus aureus, such as Echinacea angustifolia. Nanosuspensions containing these nanoparticles exhibit greater antimicrobial activity than free extracts since they inhibit biofilm formation and down-regulate genes associated with biofilm formation. Such developments demonstrate the applications of nanotechnology in eradicating MDR strains that normal antibiotics are incapable of controlling.

Erasure and Prevention of Biofilms

Biofilms on the surfaces that are necessary for bacterial communities to form a protective matrix against microbes are very essential and lead to chronic infections and resistance. Interestingly, the application of nanotechnology has come up as a solution to enhancing physical access to penetrate biofilms. Loading antimicrobial agents into nanoparticles improves their stability and ensures they are released in a strategic position within bacteria entrenched in the biofilm.

Loading antibacterial agents into the nanocarriers that can control their release has proven effective in reducing the established biofilm structure and bacterial viability. For example, alginate-chitosan nanoparticles containing plant extract have been developed to suppress biofilm-related genes of Staphylococcus aureus and reduce the MIC of the treatment profoundly. Slow and selective release of natural antagonists of microbes not only deconstructs biofilm morphology but also limits the destruction of cell tissue.

Yearwise Publication Trend on “multidrug resistant”

Find publication trends on relevant topics

It therefore follows that we turn our focus to targeted drug delivery systems

Nanotechnology also allows the targeted release of antimicrobial agents at the site of infection in addition to minimizing the side effects of the antimicrobial agents. Liposomes, solid lipid nanoparticles, and dendrimers are some of the most preferred nanocarriers used in drug delivery of MDR infections. These carriers help to shield the encapsulated drug from unbenevolent degradation processes, enhance its disponibility, and enable time-controlled release at the site of infection.

Targeted delivery systems also include ligands that bind with the bacterial surface receptors, thus improving specificity. For example, antibody- or peptide-conjugated nanoparticles that preferentially adhere to bacterial cell surfaces will have limited side effects. Ideally, such specific methods are valuable in fighting refractory microorganisms while avoiding the alteration of the host-associated microflora.

Application of Nanotechnology in Social Controlling of Resistance Mechanisms

Organisms have innate defense mechanisms, which are part of mechanisms that make bacteria resistant to antibiotics; these mechanisms include efflux pumps, enzymatic degradation, and gene mutations. These mechanisms may be bypassed or quenched by the nanoparticles. For instance, silver nanoparticles exert a membrane disruption mechanism that does not involve interaction with the efflux pump while readily interacting with the bacterial cell wall. The research also shows that gold nanoparticles have been designed to inhibit enzymatic activities to hinder the degradation of antibiotics.

Nanotechnology also enhances the methods of combination therapies, for example, the use of nanoparticles to deliver antibiotics and other substances that reduce resistance at the same time. This approach increases the effectiveness of previously utilized antibiotics by bypassing the resistance profiles to be used on MDR strains.

Emerging Trends: Natural Nanomaterials

There is a gradually increasing focus on incorporating natural materials into nanotechnology delivery of antimicrobial methods. Considering that plant extracts and essential oils have demonstrated antibacterial properties, it is interesting to see that the former is added to nanoparticles to improve their stability and biological activity. From the bioactive constituent of clove oil, namely eugenol, nanoemulsions have been prepared and exhibit enhanced potential in enhancing gut barrier functions and immunity, besides preventing pathogenic infections.

Plant-derived nanoparticles offer a dual advantage: they are biocompatible carriers for therapeutic agents, and they intrinsically exhibit antimicrobial characteristics. They are such breakthroughs that are sustainable in addressing the MDR infections.

Recent Publications on “multidrug resistant”

Find publications on relevant topics

Chosen applications summarized into Diagnostics and Biosensing

Proper and early diagnosis of MDR infections is very important as a basis for treating them. Diagnostic technology has been an area that has benefited from nanotechnology through the creation of biosensors and imaging systems. Cationic nanoparticles tagged with specific ligands or dyes facilitate the detection of bacterial pathogens and their corresponding resistance. These nanosensors are highly sensitive as well as highly specific, thereby enabling early treatment.

For example, fluorescent carbon nanotubes have been employed for the identification of bacterial metabolites and chemokines with information on biofilm formation and bacterial action. Likewise, magnetic nanoparticles have been incorporated into diagnostic tools for pathogen identification and estimation of drug effectiveness at high throughput rates.

Preventing healthcare-related infections

The following are the repeated infections acquired in the hospital by MDR pathogens: Hospital-acquired infections (HAIs). Coatings and materials at the nano-level are currently under research for use in combating bacterial attachment and growth on medical instruments. Incorporation of nanoparticles into anti-fouling coatings alters the bacteria environment, decreasing HAIs.

Moreover, parents have been used in the production of antimicrobial dressings and coatings for wound care. They give off antimicrobial substances in controlled phases to avoid further complications of the injury and to enhance the closing process.

Issues and Prospects

Thus, there are several limitations to nanotechnology as an approach against MDR infections, despite its incredible potential. The use of nanoparticles for long-term applications must also be adequately safe for the body and the environment because nanoparticles, once introduced, are difficult to remove from the human body. Lack of regulatory support and high production costs are also challenges to the use of nanotechnology-based solutions.

Future studies were aimed at maximizing the synthesis and functionalization of nanoparticles for more appropriate uses. A microbiologist, chemist, and engineer will have to work hand in hand in the future because the novel advancements in the lab will require implementation in the clinic. Moreover, the research conducted by the public and private sectors directed to nanotechnology shall foster better and more financially efficient, as well as a more scalable solution to MDR infection.

Conclusion

Using nanotechnology is thus a revolutionary idea for combating multidrug-resistant infections all over the world. Due to the unique inherent characteristics of nanoparticles, new strategies have been established to counteract resistance mechanisms, prevent biofilm formation, control drug release, and improve diagnostic modalities. The integration of natural 

The development of new compounds and targeted delivery systems widens the application of nanotechnology in fighting these diseases twofold. Despite such development, nanotechnology is expected to give antimicrobial therapy a new outlook towards the future of mankind.

References

  1. Taghiloo, S., Ghajari, G., Zand, Z., Kabiri‐Samani, S., Kabiri, H., Rajaei, N. and Piri‐Gharaghie, T., 2023. Designing alginate/chitosan nanoparticles containing echinacea angustifolia: a novel candidate for combating multidrug‐resistant staphylococcus aureus. Chemistry & Biodiversity, 20(7), p.e202201008.
  2. Ananda, T., Modi, A., Chakraborty, I., Managuli, V., Mukhopadhyay, C. and Mazumder, N., 2022. Nosocomial infections and role of nanotechnology. Bioengineering, 9(2), p.51.
  3. Ibrahim, D., Eldemery, F., Metwally, A.S., Abd-Allah, E.M., Mohamed, D.T., Ismail, T.A., Hamed, T.A., Al Sadik, G.M., Neamat-Allah, A.N. and Abd El-Hamid, M.I., 2022. Dietary eugenol nanoemulsion potentiated performance of broiler chickens: Orchestration of digestive enzymes, intestinal barrier functions and cytokines related gene expression with a consequence of attenuating the severity of E. coli O78 infection. Frontiers in Veterinary Science, 9, p.847580.
  4. Deng, K., Yang, D. and Zhou, Y., 2022. Nanotechnology-based siRNA delivery systems to overcome tumor immune evasion in cancer immunotherapy. Pharmaceutics, 14(7), p.1344.
  5. Intarabut, D., Sukontasukkul, P., Phoo-Ngernkham, T., Zhang, H., Yoo, D.Y., Limkatanyu, S. and Chindaprasirt, P., 2022. Influence of graphene oxide nanoparticles on bond-slip reponses between fiber and geopolymer mortar. Nanomaterials, 12(6), p.943.
  6. Zhang, J., Huang, L., Ge, G. and Hu, K., 2023. Emerging epigenetic‐based nanotechnology for cancer therapy: modulating the tumor microenvironment. Advanced Science, 10(7), p.2206169.
  7. Gupta, V., Mohapatra, S., Mishra, H., Farooq, U., Kumar, K., Ansari, M.J., Aldawsari, M.F., Alalaiwe, A.S., Mirza, M.A. and Iqbal, Z., 2022. Nanotechnology in cosmetics and cosmeceuticals—a review of latest advancements. Gels, 8(3), p.173.
  8. Gonçalves, B.C., Lopes Barbosa, M.G., Silva Olak, A.P., Belebecha Terezo, N., Nishi, L., Watanabe, M.A., Marinello, P., Zendrini Rechenchoski, D., Dejato Rocha, S.P. and Faccin‐Galhardi, L.C., 2021. Antiviral therapies: advances and perspectives. Fundamental & Clinical Pharmacology, 35(2), pp.305-320.

Top Experts on “multidrug resistant“